Zentralbl Chir 2015; 140(04): 407-416
DOI: 10.1055/s-0032-1328594
Übersicht
Georg Thieme Verlag KG Stuttgart · New York

Nutritive Defizite nach bariatrischer Chirurgie – systematische Literaturanalyse und Empfehlungen für Diagnostik und Substitution[*]

Nutrient Deficiencies after Bariatric Surgery – Systematic Literature Review and Suggestions for Diagnostics and Treatment
C. Stroh
1   Klinik für Allgemein-, Viszeral- und Kinderchirurgie, SRH Wald-Klinikum Gera gGmbH, Gera, Deutschland
,
F. Benedix
2   Klinik für Allgemein-, Viszeral- und Gefäßchirurgie, Universitätsklinikum Magdeburg A. ö. R., Magdeburg, Deutschland
,
F. Meyer
2   Klinik für Allgemein-, Viszeral- und Gefäßchirurgie, Universitätsklinikum Magdeburg A. ö. R., Magdeburg, Deutschland
,
T. Manger
1   Klinik für Allgemein-, Viszeral- und Kinderchirurgie, SRH Wald-Klinikum Gera gGmbH, Gera, Deutschland
› Author Affiliations
Further Information

Publication History

Publication Date:
03 July 2013 (online)

Zusammenfassung

Die zunehmende Prävalenz der morbiden Adipositas geht auch in Deutschland mit einer deutlichen Zunahme von adipositas- und metabolisch-chirurgischen Eingriffen einher. Chirurgische und insbesondere metabolische Langzeitkomplikationen können Folge verschiedener restriktiver und malabsorptiver Operationsmethoden sein. Das Ziel der kompakten Kurzübersicht ist es, basierend auf einer selektiven Literaturrecherche und eigenen klinischen Erfahrungen die metabolischen Langzeitkomplikationen, die mit den verschiedenen bariatrischen Eingriffen assoziiert sind, darzustellen einschließlich der davon abzuleitenden Richtlinien einer Supplementation. Nach restriktiven OP-Verfahren wie dem Gastric Banding und der Sleeve-Gastrektomie sind Pouchdilatation und Bandmigration ebenso wie eine Refluxerkrankung schwerwiegende Langzeitkomplikationen. Nutritive Defizite nach restriktiven Verfahren betreffen meist die B-Vitamine. Malabsorptive Methoden wie die biliopankreatische Diversion, der Duodenal Switch und der Magenbypass sind mit Eisen-, Folsäure-, Vitamin-B1-, Vitamin-B12- und Vitamin-D-Defiziten assoziiert. Aufgrund der metabolischen und chirurgischen Komplikationen nach adipositaschirurgischen Eingriffen muss eine lebenslange Nachsorge der Patienten erfolgen. Die derzeitigen Leitlinien der Chirurgischen Arbeitsgemeinschaft Adipositastherapie (CAADIP) der DGAV zur Supplementation sollten dem klinisch tätigen Adipositas- und metabolischen Chirurgen hinsichtlich seiner obligatorischen Weiterbetreuungsverpflichtung nachhaltig bewusst sein.

Abstract

The increasing prevalence of morbid obesity in Germany is associated with an increasing number of metabolic surgical interventions. Short-term surgical and long-term metabolic complications such as nutrient deficiencies can be considered the main risks of metabolic surgery and its restrictive and malabsorbant surgical procedures. The aim of this compact short overview based on a selective literature search and our own clinical experience is to characterise the long-term metabolic complications, which are specific for the various bariatric procedures, and to refine the published guidelines for supplementation. Restrictive bariatric procedures can be associated with well-known surgical problems such as pouch dilatation or band migration, e.g., after gastric banding. After sleeve gastrectomy, emerging reflux disease can become a substantial problem. The most frequent deficiencies after restrictive procedures are related to B-vitamins whereas iron, folate, vitamin B1 and B12 and vitamin D deficiencies are associated with the malabsorptive procedure such as biliopancreatic diversion, duodenal switch and Roux-en-Y gastric bypass. Due to possible metabolic and surgical complications after bariatric surgery, patients need to undergo life-long medical follow-up investigations. The currently available guidelines of German Society of Treatment of Obesity (CAADIP) of DGAV for supplementation should be known and followed, in particular, by the physicians who i) are exceptionally involved in medical care of obese people and ii) do it in full awareness of the obligatory postoperative clinical observation.

* Prof. Dr. Dr. H. Lippert gewidmet


 
  • Literatur

  • 1 Lampert T. Übergewicht und Adipositas in Deutschland. 2007; 18: 155-156
  • 2 Statistisches-Bundesamt. Mikrozensus – Fragen zur Gesundheit – Körpermaße der Bevölkerung 2009. Wiesbaden: Statistisches Bundesamt, Selbstverlag; 2010
  • 3 Sjöström L, Peltonen M, Jacobson P et al. Bariatric surgery and long-term cardiovascular events. JAMA 2012; 307: 56-65
  • 4 Ikramuddin S, Buchwald H. How bariatric and metabolic operations control metabolic syndrome. Br J Surg 2011; 98: 1339-1341
  • 5 Malinowski SS. Nutritional and metabolic complications after bariatric surgery. Am J Med Sci 2006; 331: 219-225
  • 6 Hakeam HA, OʼRegan P, Salem AM et al. Impact of laparoscopic sleeve gastrectomy on iron indices: 1 year follow-up. Obes Surg 2009; 19: 1491-1496
  • 7 Aarts EO, Janssen IMC, Berends FJ. The gastric sleeve: Losing weight as fast as micronutrients?. Obes Surg 2011; 21: 207-211
  • 8 Gehrer S, Kern B, Peters T et al. Fewer nutrient deficiencies after Laparoscopic Sleeve Gastrectomy (LSG) than after Laparoscopic Roux-Y-Gastric-Bypass (LRYGBP) – a prospective study. Obes Surg 2010; 20: 447-453
  • 9 Brolin RE, Gorman JH, Robert C et al. Prophylactic iron supplementation after Roux-en-Y gastric bypass: A prospective, double blind, randomized study. Arch Surg 1998; 137: 740-744
  • 10 Skroubis G, Sakellaropoulos G, Pouggouras K et al. Comparison of nutritional deficiencies after Roux-en-Y gastric bypass and after biliopancreatic diversion with Roux-en-Y gastric bypass. Obes Surg 2002; 12: 551-558
  • 11 Cable CT, Colbert CY, Showalter T et al. Prevalence of anemia after Roux-en-Y gastric bypass surgery: what is the right number?. SOARD 2011; 7: 134-139
  • 12 Von Drygalski A, Andris DA, Nuttleman PR et al. Anemia after bariatric surgery cannot be explained by iron deficiency alone: results of a large cohort study. SOARD 2011; 7: 151-156
  • 13 Halverson JD. Micronutrient deficiencies after gastric bypass for morbid obesity. Am Surg 1986; 52: 594-598
  • 14 Brolin RE, Gorman RC, Milgrim LM et al. Multivitamin prophylaxis in prevention of post-gastric bypass vitamin and mineral deficiencies. Int J Obes 1991; 15: 661-667
  • 15 Brolin RE, Kenler HA, Gorman JH et al. Long-limb gastric bypass in the superobese. A prospective randomized study. Ann Surg 1992; 215: 387-395
  • 16 Kalfarentzos F, Dimakopoulos A, Kehagias I et al. Vertical banded gastroplasty versus standard or distal Roux-en-Y gastric bypass based on specific selection criteria in the morbidly obese: preliminary results. Obes Surg 1999; 9: 433-442
  • 17 Brolin RE, LaMarca LB, Kenler HA et al. Malabsorptive gastric bypass in patients with superobesity. J Gastrointest Surg 2002; 6: 195-203
  • 18 Coupaye M, Puchaux K, Bogard C et al. Nutritional consequences of adjustable gastric banding and gastric bypass: a 1-year prospective study. Obes Surg 2009; 19: 56-65
  • 19 Dolan K, Hatzifotis M, Newbury L et al. A clinical and nutritional comparison of biliopancreatic diversion with and without duodenal switch. Ann Surg 2004; 240: 51-56
  • 20 Rabkin RA, Rabkin JM, Metcalf B et al. Nutritional markers following duodenal switch for morbid obesity. Obes Surg 2004; 14: 84-90
  • 21 Brolin RE, Gorman JH, Gorman RC. Are vitamin B12 and folate deficiency clinically important after Roux-en-Y gastric bypass?. J Gastrointest Surg 1998; 2: 436-442
  • 22 Simon SR, Zemel R, Betancourt S et al. Hematologic complications of gastric bypass for morbid obesity. South Med J 1989; 82: 1108-1110
  • 23 Mallory GN, Macgregor AMC. Folate status following gastric bypass surgery. The great folate mystery. Obes Surg 1991; 1: 69-72
  • 24 Stroh C, Meyer F, Lippert H et al. Die Beriberi, eine seltene, aber schwerwiegende nutritive Komplikation nach bariatrischen Eingriffen: Inzidenz, Symptomatologie, Therapie und Prävention. Viszeralmedizin 2010; 26: 41-46
  • 25 Kehagias I, Karamanakos SN, Argentou M et al. Randomized clinical trial of laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy for the management of patients with BMI < 50 kg/m². Obes Surg 2011; 21: 1650-1656
  • 26 Sugerman HJ, Kellum JM, Engle KM et al. Gastric bypass for treating severe obesity. Am J Clin Nutr 1992; 55 (2 Suppl) 560S-566S
  • 27 Rhode BM, Arseneau P, Cooper BA et al. Vitamin B-12 deficiency after gastric surgery for obesity. Am J Clin Nutr 1996; 63: 103-109
  • 28 Clements RH, Katasani VG, Palepu R et al. Incidence of vitamin deficiency after laparoscopic Roux-en-Y gastric bypass in a university hospital setting. Am Surg 2006; 72: 1196-1202 discussion 1203–1204
  • 29 Kalfarentzos F, Skroubis G, Kehagias I et al. A prospective comparison of vertical banded gastroplasty and Roux-en-Y gastric bypass in a non-superobese population. Obes Surg 2006; 16: 151-158
  • 30 Brolin RE, Leung M. Survey of vitamin and mineral supplementation after gastric bypass and biliopancreatic diversion for morbid obesity. Obes Surg 1999; 9: 150-154
  • 31 Marceau P, Hould FS, Simard S et al. Biliopancreatic Diversion with Duodenal Switch. World J Surg 1998; 22: 947-954
  • 32 Stroh C, Weiher C, Hohmann U et al. Vitamin A deficiency (VAD) after a duodenal switch procedure: A case report. Obes Surg 2010; 20: 397-400
  • 33 Slater GH, Ren CJ, Siegel N et al. Serum fat-soluble vitamin deficiency and abnormal calcium metabolism after malabsorptive bariatric surgery. J Gastrointest Surg 2004; 8: 48-55 discussion 54–55
  • 34 Davies DJ, Baxter JM, Baxter JN. Nutritional deficiencies after bariatric surgery. Obes Surg 2007; 17: 1150-1158
  • 35 Flancbaum L, Belsley S, Drake S. Preoperative nutritional status of patients undergoing Roux-en-Y gastric bypass for morbid obesity. J Gastrointest Surg 2006; 10: 1033-1037
  • 36 Ducloux R, Nobécourt E, Chevallier JM et al. Vitamin D deficiency before bariatric surgery: should supplement intake be routinely prescribed?. Obes Surg 2011; 21: 556-560
  • 37 Pugnale N, Giusti V, Suter M et al. Bone metabolism and risk of secondary hyperparathyroidism 12 months after gastric banding in obese pre-menopausal women. Int J Obes Relat Metab Disord 2003; 27: 110-116
  • 38 Giusti V, Gasteyger C, Suter M et al. Gastric banding induces negative bone remodelling in the absence of secondary hyperparathyroidism: potential role of serum C telopeptides for follow-up. Int J Obes 2005; 29: 1429-1435
  • 39 Sánchez-Hernández J, Ybarra J, Gich I et al. Effects of bariatric surgery on vitamin D status and secondary hyperparathyroidism: a prospective study. Obes Surg 2005; 15: 1389-1395
  • 40 Carlin AM, Rao DS, Yager KM et al. Effect of gastric bypass surgery on vitamin D nutritional status. SOARD 2006; 2: 638-642
  • 41 Johnson JM, Maher JW, DeMaria EJ et al. The long-term effects of gastric bypass on vitamin D metabolism. Ann Surg 2006; 243: 701-704
  • 42 Jin J, Robinson AV, Hallowell PT et al. Increases in parathyroid hormone (PTH) after gastric bypass surgery appears to be of a secondary nature. Surgery 2007; 142: 914-920 discussion 914–920
  • 43 Youssef Y, Richards WO, Sekhar N et al. Risk of secondary hyperparathyreoidism after laparoscopic gastric bypass surgery in obese women. Surg Endos 2007; 21: 1393-1396
  • 44 Ybarra J, Sánchez-Hernández J, Gich I et al. Unchanged hypovitaminosis D and secondary hyperparathyroidism in morbid obesity after bariatric surgery. Obes Surg 2005; 15: 330-335
  • 45 Marceau P, Biron S, Lebel S et al. Does bone change after biliopancreatic diversion?. J Gastrointest Surg 2002; 6: 690-698
  • 46 Hamoui N, Kim K, Anthone G et al. The significance of elevated levels of parathyroid hormone in patients with morbid obesity before and after bariatric surgery. Arch Surg 2003; 138: 891-897
  • 47 Newbury L, Dolan K, Hatzifotis M et al. Calcium and vitamin D depletion and elevated parathyroid hormone following biliopancreatic diversion. Obes Surg 2003; 13: 893-895
  • 48 Hamoui N, Anthone G, Crookes PF. Calcium metabolism in the morbidly obese. Obes Surg 2004; 14: 9-12
  • 49 Marceau P, Biron S, Hould FS et al. Duodenal switch: long-term results. Obes Surg 2007; 17: 1421-1430
  • 50 Moreiro J, Ruiz O, Perez G et al. Parathyroid hormone and bone marker levels in patients with morbid obesity before and after biliopancreatic diversion. Obes Surg 2007; 17: 348-354
  • 51 Alvarez-Leite JI. Nutrient deficencies secondary to bariatric surgery. Curr Opin Clin Metab Care 2004; 7: 569-575
  • 52 Mason EE. Bone disease from duodenal exclusion. Obes Surg 2000; 10: 585-586
  • 53 Magee CJ, Barry J, Brocklehurst J et al. Outcome of laparoscopic duodenal switch for morbid obesity. Br J Surg 2011; 98: 79-84
  • 54 Parkes E. Nutritional management of patients after bariatric surgery. Am J Med Sci 2006; 331: 207-213
  • 55 Faintuch J, Matsuda M, Cruz ME et al. Severe protein-calorie malnutrition after bariatric procedures. Obes Surg 2004; 14: 175-181
  • 56 Marceau S, Biron S, Lagacé M et al. Biliopancreatic Diversion, with Distal Gastrectomy, 250 cm and 50 cm Limbs: Long-term Results. Obes Surg 1995; 5: 302-307
  • 57 Nanni G, Balduzzi GF, Capoluongo R et al. Biliopancreatic diversion: clinical experience. Obes Surg 1997; 7: 26-29
  • 58 Gagner M, Boza C. Laparoscopic duodenal switch for morbid obesity. Expert Rev Med Devices 2006; 3: 105-112
  • 59 Stroh C, Wolff S, Manger T. [Report on the XVIth World Congress of the International Federation of Bariatric and Metabolic Surgery in Hamburg 2011]. Zentralbl Chir 2011; 136: 631-633
  • 60 Stroh C, Hohmann U, Weiher C et al. Die derzeit bekannten Langzeitfolgen nach bariatrischen Eingriffen und ihr Vermeiden. MIC 2008; 17: 77-80
  • 61 Ernst B, Thurnheer M, Schmid SM et al. Evidence for the necessity to systematically assess micronutrient status prior to bariatric surgery. Obes Surg 2009; 19: 66-73
  • 62 Stroh C, Manger T. Studie zur Qualitätskontrolle der operativen Therapie der Adipositas. Mitt Dtsch Ges Chir 2004; 33: 389-391
  • 63 Stroh C, Weiner R, Horbach T et al. Aktuelle Daten der Qualitätssicherungsstudie für operative Therapie der Adipositas in Deutschland. Zentralbl Chir 2013; 138: 180-188